1. Home
  2. INTG vs CVKD Comparison

INTG vs CVKD Comparison

Compare INTG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTG
  • CVKD
  • Stock Information
  • Founded
  • INTG 1965
  • CVKD 2022
  • Country
  • INTG United States
  • CVKD United States
  • Employees
  • INTG N/A
  • CVKD N/A
  • Industry
  • INTG Building operators
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • INTG Real Estate
  • CVKD Health Care
  • Exchange
  • INTG Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • INTG 30.8M
  • CVKD 26.3M
  • IPO Year
  • INTG N/A
  • CVKD 2023
  • Fundamental
  • Price
  • INTG $14.34
  • CVKD $17.04
  • Analyst Decision
  • INTG
  • CVKD Strong Buy
  • Analyst Count
  • INTG 0
  • CVKD 2
  • Target Price
  • INTG N/A
  • CVKD $46.00
  • AVG Volume (30 Days)
  • INTG 6.3K
  • CVKD 84.2K
  • Earning Date
  • INTG 11-13-2024
  • CVKD 11-07-2024
  • Dividend Yield
  • INTG N/A
  • CVKD N/A
  • EPS Growth
  • INTG N/A
  • CVKD N/A
  • EPS
  • INTG N/A
  • CVKD N/A
  • Revenue
  • INTG $59,536,000.00
  • CVKD N/A
  • Revenue This Year
  • INTG N/A
  • CVKD N/A
  • Revenue Next Year
  • INTG N/A
  • CVKD N/A
  • P/E Ratio
  • INTG N/A
  • CVKD N/A
  • Revenue Growth
  • INTG 0.93
  • CVKD N/A
  • 52 Week Low
  • INTG $13.65
  • CVKD $5.40
  • 52 Week High
  • INTG $28.85
  • CVKD $32.55
  • Technical
  • Relative Strength Index (RSI)
  • INTG 44.26
  • CVKD 57.77
  • Support Level
  • INTG $14.18
  • CVKD $16.25
  • Resistance Level
  • INTG $14.41
  • CVKD $19.97
  • Average True Range (ATR)
  • INTG 0.47
  • CVKD 1.80
  • MACD
  • INTG 0.08
  • CVKD -0.04
  • Stochastic Oscillator
  • INTG 49.23
  • CVKD 54.70

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: